

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.76038954 |
| 2 | lysine catabolic process (GO:0006554) | 4.70911345 |
| 3 | lysine metabolic process (GO:0006553) | 4.70911345 |
| 4 | valine metabolic process (GO:0006573) | 4.69886250 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 4.54395309 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.54395309 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.50615929 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40065355 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40065355 |
| 10 | protein complex biogenesis (GO:0070271) | 4.32063861 |
| 11 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.27845708 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 4.27845708 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.27845708 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.18234224 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 4.18167994 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 4.11539720 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09176574 |
| 18 | nonmotile primary cilium assembly (GO:0035058) | 4.05247972 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 4.03456912 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 4.00980911 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.99865151 |
| 22 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.98454716 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.83786370 |
| 24 | carnitine shuttle (GO:0006853) | 3.83165990 |
| 25 | tricarboxylic acid metabolic process (GO:0072350) | 3.78748509 |
| 26 | oxaloacetate metabolic process (GO:0006107) | 3.72140460 |
| 27 | regulation of sequestering of triglyceride (GO:0010889) | 3.67302724 |
| 28 | presynaptic membrane assembly (GO:0097105) | 3.64408122 |
| 29 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.62726328 |
| 30 | fatty acid beta-oxidation (GO:0006635) | 3.54480972 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54206042 |
| 32 | response to nitrosative stress (GO:0051409) | 3.52326840 |
| 33 | cullin deneddylation (GO:0010388) | 3.52211277 |
| 34 | sequestering of actin monomers (GO:0042989) | 3.49844590 |
| 35 | low-density lipoprotein particle clearance (GO:0034383) | 3.46271877 |
| 36 | respiratory electron transport chain (GO:0022904) | 3.46179921 |
| 37 | intraciliary transport (GO:0042073) | 3.45427415 |
| 38 | electron transport chain (GO:0022900) | 3.43021584 |
| 39 | proteasome assembly (GO:0043248) | 3.40903806 |
| 40 | carnitine metabolic process (GO:0009437) | 3.39791778 |
| 41 | regulation of cholesterol storage (GO:0010885) | 3.33335556 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 3.29947655 |
| 43 | regulation of cilium movement (GO:0003352) | 3.28721359 |
| 44 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.25796127 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.22899523 |
| 46 | positive regulation of amino acid transport (GO:0051957) | 3.21280854 |
| 47 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.18873257 |
| 48 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.18694927 |
| 49 | fatty acid oxidation (GO:0019395) | 3.18340566 |
| 50 | epithelial cilium movement (GO:0003351) | 3.17335303 |
| 51 | presynaptic membrane organization (GO:0097090) | 3.16930458 |
| 52 | intracellular protein transmembrane import (GO:0044743) | 3.15483248 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.15171331 |
| 54 | lipid oxidation (GO:0034440) | 3.14319194 |
| 55 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.12980942 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 3.12666760 |
| 57 | kynurenine metabolic process (GO:0070189) | 3.11660472 |
| 58 | GPI anchor metabolic process (GO:0006505) | 3.11354518 |
| 59 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.10490761 |
| 60 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.10490761 |
| 61 | regulation of fatty acid oxidation (GO:0046320) | 3.08620861 |
| 62 | succinate metabolic process (GO:0006105) | 3.08295630 |
| 63 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.07938874 |
| 64 | positive regulation of interferon-alpha production (GO:0032727) | 3.07369361 |
| 65 | iron-sulfur cluster assembly (GO:0016226) | 3.07323140 |
| 66 | metallo-sulfur cluster assembly (GO:0031163) | 3.07323140 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.05429270 |
| 68 | polyketide metabolic process (GO:0030638) | 3.03882752 |
| 69 | doxorubicin metabolic process (GO:0044598) | 3.03882752 |
| 70 | daunorubicin metabolic process (GO:0044597) | 3.03882752 |
| 71 | axoneme assembly (GO:0035082) | 3.03762841 |
| 72 | protein deneddylation (GO:0000338) | 3.02948492 |
| 73 | organelle disassembly (GO:1903008) | 3.02324756 |
| 74 | carnitine transmembrane transport (GO:1902603) | 3.01754887 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.00359765 |
| 76 | protein-cofactor linkage (GO:0018065) | 3.00306612 |
| 77 | neural tube formation (GO:0001841) | 2.99183385 |
| 78 | fatty acid catabolic process (GO:0009062) | 2.97644300 |
| 79 | pentose-phosphate shunt (GO:0006098) | 2.97499903 |
| 80 | branched-chain amino acid metabolic process (GO:0009081) | 2.97102161 |
| 81 | regulation of hexokinase activity (GO:1903299) | 2.96108836 |
| 82 | regulation of glucokinase activity (GO:0033131) | 2.96108836 |
| 83 | positive regulation of lipid storage (GO:0010884) | 2.95938241 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 2.94897753 |
| 85 | NADH metabolic process (GO:0006734) | 2.94764494 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.92470203 |
| 87 | glyoxylate metabolic process (GO:0046487) | 2.91871400 |
| 88 | GPI anchor biosynthetic process (GO:0006506) | 2.91403420 |
| 89 | detection of calcium ion (GO:0005513) | 2.90779564 |
| 90 | carnitine transport (GO:0015879) | 2.89785904 |
| 91 | amino-acid betaine transport (GO:0015838) | 2.89785904 |
| 92 | cellular response to zinc ion (GO:0071294) | 2.89239936 |
| 93 | complement activation, alternative pathway (GO:0006957) | 2.89000237 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 2.88118072 |
| 95 | ribonucleoprotein complex disassembly (GO:0032988) | 2.88065125 |
| 96 | negative regulation of neurotransmitter transport (GO:0051589) | 2.87782618 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 2.87324196 |
| 98 | regulation of interferon-alpha production (GO:0032647) | 2.87191988 |
| 99 | ATP biosynthetic process (GO:0006754) | 2.84186990 |
| 100 | positive regulation of prostaglandin secretion (GO:0032308) | 2.83761540 |
| 101 | DNA double-strand break processing (GO:0000729) | 2.82774047 |
| 102 | cilium movement (GO:0003341) | 2.81719969 |
| 103 | branched-chain amino acid catabolic process (GO:0009083) | 2.79617594 |
| 104 | positive regulation of mitochondrial fission (GO:0090141) | 2.79089795 |
| 105 | respiratory chain complex IV assembly (GO:0008535) | 2.79009217 |
| 106 | cysteine metabolic process (GO:0006534) | 2.78885652 |
| 107 | protein neddylation (GO:0045116) | 2.78823372 |
| 108 | positive regulation of fatty acid oxidation (GO:0046321) | 2.78271769 |
| 109 | termination of RNA polymerase III transcription (GO:0006386) | 2.78022479 |
| 110 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.78022479 |
| 111 | cilium organization (GO:0044782) | 2.77146572 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 2.74980443 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 2.74964705 |
| 114 | NADPH regeneration (GO:0006740) | 2.74602516 |
| 115 | C4-dicarboxylate transport (GO:0015740) | 2.74496473 |
| 116 | protein polyglutamylation (GO:0018095) | 2.73550860 |
| 117 | cilium morphogenesis (GO:0060271) | 2.73543373 |
| 118 | cilium assembly (GO:0042384) | 2.73174673 |
| 119 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.72727648 |
| 120 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.69644621 |
| 121 | oxidative phosphorylation (GO:0006119) | 2.68900482 |
| 122 | mannosylation (GO:0097502) | 2.67914851 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 2.66685196 |
| 124 | cytochrome complex assembly (GO:0017004) | 2.66148971 |
| 125 | biotin metabolic process (GO:0006768) | 2.65733985 |
| 126 | serotonin receptor signaling pathway (GO:0007210) | 2.65730516 |
| 127 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.65622010 |
| 128 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.65540337 |
| 129 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.65127625 |
| 130 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.64912549 |
| 131 | protein localization to cilium (GO:0061512) | 2.64885768 |
| 132 | peptidyl-histidine modification (GO:0018202) | 2.64630879 |
| 133 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63706774 |
| 134 | ethanol oxidation (GO:0006069) | 2.61953846 |
| 135 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.60974440 |
| 136 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.60966179 |
| 137 | sulfur amino acid catabolic process (GO:0000098) | 2.60346533 |
| 138 | urea cycle (GO:0000050) | 2.59760144 |
| 139 | urea metabolic process (GO:0019627) | 2.59760144 |
| 140 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.58567873 |
| 141 | regulation of coenzyme metabolic process (GO:0051196) | 2.58429908 |
| 142 | regulation of cofactor metabolic process (GO:0051193) | 2.58429908 |
| 143 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57487173 |
| 144 | chromatin remodeling at centromere (GO:0031055) | 2.57328611 |
| 145 | CENP-A containing nucleosome assembly (GO:0034080) | 2.57183277 |
| 146 | indole-containing compound catabolic process (GO:0042436) | 2.56913037 |
| 147 | indolalkylamine catabolic process (GO:0046218) | 2.56913037 |
| 148 | tryptophan catabolic process (GO:0006569) | 2.56913037 |
| 149 | establishment of protein localization to mitochondrion (GO:0072655) | 2.56879443 |
| 150 | phospholipid homeostasis (GO:0055091) | 2.56370603 |
| 151 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.56198859 |
| 152 | L-phenylalanine metabolic process (GO:0006558) | 2.56198859 |
| 153 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.56073923 |
| 154 | protein carboxylation (GO:0018214) | 2.56073923 |
| 155 | neuron cell-cell adhesion (GO:0007158) | 2.55097604 |
| 156 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.54934725 |
| 157 | neuron fate determination (GO:0048664) | 2.54589111 |
| 158 | hydrogen ion transmembrane transport (GO:1902600) | 2.54477639 |
| 159 | negative regulation of response to food (GO:0032096) | 2.52954072 |
| 160 | negative regulation of appetite (GO:0032099) | 2.52954072 |
| 161 | protein targeting to mitochondrion (GO:0006626) | 2.52759282 |
| 162 | regulation of protein activation cascade (GO:2000257) | 2.51940115 |
| 163 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51884054 |
| 164 | modulation by symbiont of host defense response (GO:0052031) | 2.51884054 |
| 165 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51884054 |
| 166 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51884054 |
| 167 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51884054 |
| 168 | modulation by symbiont of host immune response (GO:0052553) | 2.51884054 |
| 169 | platelet dense granule organization (GO:0060155) | 2.50741557 |
| 170 | aromatic amino acid family catabolic process (GO:0009074) | 2.50445918 |
| 171 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50297432 |
| 172 | tryptophan metabolic process (GO:0006568) | 2.48751972 |
| 173 | protein localization to mitochondrion (GO:0070585) | 2.47508720 |
| 174 | DNA integration (GO:0015074) | 2.47012304 |
| 175 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46625225 |
| 176 | positive regulation of organic acid transport (GO:0032892) | 2.46206919 |
| 177 | response to pheromone (GO:0019236) | 2.45994010 |
| 178 | regulation of complement activation (GO:0030449) | 2.45991986 |
| 179 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.45474142 |
| 180 | proton transport (GO:0015992) | 2.45136248 |
| 181 | aggressive behavior (GO:0002118) | 2.44491050 |
| 182 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.44482051 |
| 183 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.44444897 |
| 184 | ribosomal small subunit assembly (GO:0000028) | 2.43425249 |
| 185 | intracellular lipid transport (GO:0032365) | 2.43178447 |
| 186 | quaternary ammonium group transport (GO:0015697) | 2.42778022 |
| 187 | hydrogen transport (GO:0006818) | 2.42174662 |
| 188 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41576162 |
| 189 | intracellular protein transmembrane transport (GO:0065002) | 2.41159945 |
| 190 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.39987256 |
| 191 | xenobiotic catabolic process (GO:0042178) | 2.39902930 |
| 192 | inner mitochondrial membrane organization (GO:0007007) | 2.39687336 |
| 193 | triglyceride catabolic process (GO:0019433) | 2.39353383 |
| 194 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.37762494 |
| 195 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.36711588 |
| 196 | sarcomere organization (GO:0045214) | 2.36321596 |
| 197 | retinal ganglion cell axon guidance (GO:0031290) | 2.35883474 |
| 198 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.35452464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.51223535 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.10745741 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08804656 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.63431534 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57296215 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.52338946 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.23415566 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.06525372 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.95609005 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.94582273 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.90790047 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.89243328 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.87539053 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81247750 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74177780 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.70526760 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.70278927 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68875301 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.59574248 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.50530647 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50386581 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45012197 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.43301573 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 2.41957963 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.41284981 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34229667 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 2.31480556 |
| 28 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.31156806 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.23606405 |
| 30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.23193186 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16718989 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15988479 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.13035786 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12332642 |
| 35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.09052633 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06784380 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06432331 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.06381199 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04973821 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02091418 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01845486 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00734096 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00049730 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.99443270 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97733927 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95703835 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94006188 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.93049258 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91247196 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86055719 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85693131 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.82773500 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80173370 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.76081247 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74220934 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74217237 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71848187 |
| 58 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71254003 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69487503 |
| 60 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63869168 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63332938 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.61851420 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60763891 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.60105926 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57410148 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.56432851 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55688607 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54562243 |
| 69 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54534228 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.54073320 |
| 71 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.53307956 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53102339 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.52834523 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51991572 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.50629698 |
| 76 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.50419986 |
| 77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47592350 |
| 78 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44315766 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44196152 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.43609986 |
| 81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.43266776 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42141072 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41653515 |
| 84 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40610076 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.40459958 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40411295 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39318710 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38459255 |
| 89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37560487 |
| 90 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.35087466 |
| 91 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34807457 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34683134 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34405183 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33168236 |
| 95 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32922025 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31381171 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30968691 |
| 98 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29219663 |
| 99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27954500 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26613110 |
| 101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25840576 |
| 102 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25694901 |
| 103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25619026 |
| 104 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25619026 |
| 105 | MYB_26560356_Chip-Seq_TH2_Human | 1.25515344 |
| 106 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25385045 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22709857 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21260176 |
| 109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20737721 |
| 110 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.20645568 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20583494 |
| 112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.19902345 |
| 113 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19319748 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19222320 |
| 115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19213857 |
| 116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18911270 |
| 117 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18394388 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18355332 |
| 119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17736389 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17667131 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16784445 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15951838 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15703388 |
| 124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15464265 |
| 125 | MYB_26560356_Chip-Seq_TH1_Human | 1.14774368 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14733964 |
| 127 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13884752 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13591154 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13498519 |
| 130 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13012797 |
| 131 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12739844 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11889110 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11579165 |
| 134 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11301434 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11236840 |
| 136 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11006780 |
| 137 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10482096 |
| 138 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10000112 |
| 139 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09985663 |
| 140 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08806416 |
| 141 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07783201 |
| 142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07765948 |
| 143 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07170785 |
| 144 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06903136 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06699630 |
| 146 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06671210 |
| 147 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.06234569 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05416350 |
| 149 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04880771 |
| 150 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04247724 |
| 151 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04186433 |
| 152 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04186433 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04180193 |
| 154 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04110430 |
| 155 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04007431 |
| 156 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04007431 |
| 157 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03766208 |
| 158 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03012905 |
| 159 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02255153 |
| 160 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02078114 |
| 161 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02054078 |
| 162 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02030072 |
| 163 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01827330 |
| 164 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01553626 |
| 165 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01036098 |
| 166 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01034574 |
| 167 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00429304 |
| 168 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99600938 |
| 169 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99355234 |
| 170 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99025489 |
| 171 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99025489 |
| 172 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98924222 |
| 173 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98890660 |
| 174 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98626642 |
| 175 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98414101 |
| 176 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98111879 |
| 177 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97823825 |
| 178 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97352336 |
| 179 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97202145 |
| 180 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95689991 |
| 181 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95514337 |
| 182 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91100820 |
| 183 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90175026 |
| 184 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90090536 |
| 185 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89867340 |
| 186 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89383427 |
| 187 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89217856 |
| 188 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88856414 |
| 189 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88761396 |
| 190 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87311946 |
| 191 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86934150 |
| 192 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86864636 |
| 193 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86091937 |
| 194 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85490208 |
| 195 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85363129 |
| 196 | MAF_26560356_Chip-Seq_TH2_Human | 0.84202815 |
| 197 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83526765 |
| 198 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82019488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.24655124 |
| 2 | MP0005360_urolithiasis | 3.07166098 |
| 3 | MP0006292_abnormal_olfactory_placode | 2.99019027 |
| 4 | MP0003880_abnormal_central_pattern | 2.71766665 |
| 5 | MP0001529_abnormal_vocalization | 2.67838927 |
| 6 | MP0001984_abnormal_olfaction | 2.67420276 |
| 7 | MP0003646_muscle_fatigue | 2.65894555 |
| 8 | MP0005365_abnormal_bile_salt | 2.62442782 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.53913689 |
| 10 | MP0008789_abnormal_olfactory_epithelium | 2.45317146 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.43586106 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.43573154 |
| 13 | MP0004130_abnormal_muscle_cell | 2.32728700 |
| 14 | MP0002102_abnormal_ear_morphology | 2.26052763 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.25220403 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 2.18020644 |
| 17 | MP0002234_abnormal_pharynx_morphology | 2.17354635 |
| 18 | MP0005499_abnormal_olfactory_system | 2.12000452 |
| 19 | MP0005394_taste/olfaction_phenotype | 2.12000452 |
| 20 | MP0002822_catalepsy | 2.06390716 |
| 21 | MP0003122_maternal_imprinting | 2.06143059 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.03700074 |
| 23 | MP0004147_increased_porphyrin_level | 2.00806733 |
| 24 | MP0002638_abnormal_pupillary_reflex | 1.96076957 |
| 25 | MP0005670_abnormal_white_adipose | 1.95180573 |
| 26 | MP0009840_abnormal_foam_cell | 1.94766576 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.94212930 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.93785802 |
| 29 | MP0003436_decreased_susceptibility_to | 1.89211726 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.88406670 |
| 31 | MP0008058_abnormal_DNA_repair | 1.84500162 |
| 32 | MP0003186_abnormal_redox_activity | 1.81858946 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.80772649 |
| 34 | MP0008995_early_reproductive_senescence | 1.78627615 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.78287912 |
| 36 | MP0003252_abnormal_bile_duct | 1.77478938 |
| 37 | MP0003011_delayed_dark_adaptation | 1.75321322 |
| 38 | MP0008872_abnormal_physiological_respon | 1.68960902 |
| 39 | MP0001486_abnormal_startle_reflex | 1.68872873 |
| 40 | MP0004742_abnormal_vestibular_system | 1.68394397 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.66155928 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.65746816 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.65581266 |
| 44 | MP0003787_abnormal_imprinting | 1.65525077 |
| 45 | MP0005253_abnormal_eye_physiology | 1.65320437 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.65000789 |
| 47 | MP0002272_abnormal_nervous_system | 1.64973188 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.64568582 |
| 49 | MP0004142_abnormal_muscle_tone | 1.62304032 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.61527562 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60389239 |
| 52 | MP0003121_genomic_imprinting | 1.59616040 |
| 53 | MP0009785_altered_susceptibility_to | 1.59307537 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.59286794 |
| 55 | MP0009046_muscle_twitch | 1.57608348 |
| 56 | MP0009745_abnormal_behavioral_response | 1.56011811 |
| 57 | MP0001485_abnormal_pinna_reflex | 1.55714633 |
| 58 | MP0000609_abnormal_liver_physiology | 1.55133345 |
| 59 | MP0001853_heart_inflammation | 1.54505506 |
| 60 | MP0005332_abnormal_amino_acid | 1.53811566 |
| 61 | MP0002736_abnormal_nociception_after | 1.51894785 |
| 62 | MP0009764_decreased_sensitivity_to | 1.50660605 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.50265907 |
| 64 | MP0005330_cardiomyopathy | 1.49587584 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.49389640 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.49311786 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49167988 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.48589637 |
| 69 | MP0008877_abnormal_DNA_methylation | 1.47740541 |
| 70 | MP0000749_muscle_degeneration | 1.47121746 |
| 71 | MP0003136_yellow_coat_color | 1.44632346 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.43472379 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.43396101 |
| 74 | MP0001968_abnormal_touch/_nociception | 1.42952956 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.42505404 |
| 76 | MP0002938_white_spotting | 1.42323513 |
| 77 | MP0000343_altered_response_to | 1.41576979 |
| 78 | MP0004510_myositis | 1.40840297 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.40338734 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.39156612 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.38116076 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.35886573 |
| 83 | MP0001293_anophthalmia | 1.34470460 |
| 84 | MP0000685_abnormal_immune_system | 1.34034023 |
| 85 | MP0004087_abnormal_muscle_fiber | 1.32703745 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.32685584 |
| 87 | MP0002419_abnormal_innate_immunity | 1.31358092 |
| 88 | MP0004885_abnormal_endolymph | 1.30260067 |
| 89 | MP0005025_abnormal_response_to | 1.29548091 |
| 90 | MP0000778_abnormal_nervous_system | 1.28846835 |
| 91 | MP0000372_irregular_coat_pigmentation | 1.28427625 |
| 92 | MP0006082_CNS_inflammation | 1.27668778 |
| 93 | MP0003566_abnormal_cell_adhesion | 1.27165507 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 1.27150497 |
| 95 | MP0002064_seizures | 1.25749510 |
| 96 | MP0002006_tumorigenesis | 1.25189104 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 1.24382142 |
| 98 | MP0004270_analgesia | 1.24323832 |
| 99 | MP0005385_cardiovascular_system_phenoty | 1.24122954 |
| 100 | MP0001544_abnormal_cardiovascular_syste | 1.24122954 |
| 101 | MP0010630_abnormal_cardiac_muscle | 1.23159128 |
| 102 | MP0006054_spinal_hemorrhage | 1.22886217 |
| 103 | MP0008469_abnormal_protein_level | 1.22779929 |
| 104 | MP0003075_altered_response_to | 1.22746522 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 1.21407985 |
| 106 | MP0002557_abnormal_social/conspecific_i | 1.21324046 |
| 107 | MP0004859_abnormal_synaptic_plasticity | 1.21133887 |
| 108 | MP0001790_abnormal_immune_system | 1.20438921 |
| 109 | MP0005387_immune_system_phenotype | 1.20438921 |
| 110 | MP0009643_abnormal_urine_homeostasis | 1.20137617 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 1.18870907 |
| 112 | MP0002269_muscular_atrophy | 1.18596432 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 1.18425950 |
| 114 | MP0002972_abnormal_cardiac_muscle | 1.18420383 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 1.18129913 |
| 116 | MP0002148_abnormal_hypersensitivity_rea | 1.17822583 |
| 117 | MP0005000_abnormal_immune_tolerance | 1.16686083 |
| 118 | MP0002971_abnormal_brown_adipose | 1.15345812 |
| 119 | MP0003724_increased_susceptibility_to | 1.14893811 |
| 120 | MP0003172_abnormal_lysosome_physiology | 1.14847338 |
| 121 | MP0003303_peritoneal_inflammation | 1.14788978 |
| 122 | MP0001970_abnormal_pain_threshold | 1.13334012 |
| 123 | MP0001905_abnormal_dopamine_level | 1.13238947 |
| 124 | MP0005671_abnormal_response_to | 1.12251687 |
| 125 | MP0004133_heterotaxia | 1.11217062 |
| 126 | MP0001800_abnormal_humoral_immune | 1.11196845 |
| 127 | MP0001666_abnormal_nutrient_absorption | 1.11064325 |
| 128 | MP0005083_abnormal_biliary_tract | 1.10613936 |
| 129 | MP0004215_abnormal_myocardial_fiber | 1.10501228 |
| 130 | MP0000598_abnormal_liver_morphology | 1.10030993 |
| 131 | MP0002733_abnormal_thermal_nociception | 1.09991905 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 1.09267955 |
| 133 | MP0001545_abnormal_hematopoietic_system | 1.09267955 |
| 134 | MP0002452_abnormal_antigen_presenting | 1.08956509 |
| 135 | MP0001845_abnormal_inflammatory_respons | 1.04968356 |
| 136 | MP0002233_abnormal_nose_morphology | 1.02771093 |
| 137 | MP0008438_abnormal_cutaneous_collagen | 1.02196417 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 1.01770577 |
| 139 | MP0009763_increased_sensitivity_to | 1.01055866 |
| 140 | MP0000751_myopathy | 1.01037419 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 1.00547124 |
| 142 | MP0002063_abnormal_learning/memory/cond | 1.00137212 |
| 143 | MP0003195_calcinosis | 0.99650439 |
| 144 | MP0002723_abnormal_immune_serum | 0.99608523 |
| 145 | MP0003718_maternal_effect | 0.99174384 |
| 146 | MP0002277_abnormal_respiratory_mucosa | 0.98777133 |
| 147 | MP0002160_abnormal_reproductive_system | 0.98696294 |
| 148 | MP0001764_abnormal_homeostasis | 0.98647723 |
| 149 | MP0002067_abnormal_sensory_capabilities | 0.98215067 |
| 150 | MP0003890_abnormal_embryonic-extraembry | 0.96673354 |
| 151 | MP0010155_abnormal_intestine_physiology | 0.96232602 |
| 152 | MP0001963_abnormal_hearing_physiology | 0.96077405 |
| 153 | MP0003828_pulmonary_edema | 0.95359811 |
| 154 | MP0000026_abnormal_inner_ear | 0.95110126 |
| 155 | MP0001533_abnormal_skeleton_physiology | 0.94230279 |
| 156 | MP0004924_abnormal_behavior | 0.93628902 |
| 157 | MP0005386_behavior/neurological_phenoty | 0.93628902 |
| 158 | MP0005166_decreased_susceptibility_to | 0.92868518 |
| 159 | MP0003137_abnormal_impulse_conducting | 0.92654859 |
| 160 | MP0001819_abnormal_immune_cell | 0.92202965 |
| 161 | MP0002090_abnormal_vision | 0.91969893 |
| 162 | MP0004947_skin_inflammation | 0.91008913 |
| 163 | MP0005620_abnormal_muscle_contractility | 0.90744074 |
| 164 | MP0002420_abnormal_adaptive_immunity | 0.90557543 |
| 165 | MP0005410_abnormal_fertilization | 0.90210421 |
| 166 | MP0002138_abnormal_hepatobiliary_system | 0.89330686 |
| 167 | MP0004808_abnormal_hematopoietic_stem | 0.88330588 |
| 168 | MP0003786_premature_aging | 0.88105464 |
| 169 | MP0000383_abnormal_hair_follicle | 0.87034623 |
| 170 | MP0002398_abnormal_bone_marrow | 0.86329673 |
| 171 | MP0000858_altered_metastatic_potential | 0.85958174 |
| 172 | MP0000049_abnormal_middle_ear | 0.85750562 |
| 173 | MP0010307_abnormal_tumor_latency | 0.85392230 |
| 174 | MP0005334_abnormal_fat_pad | 0.85305853 |
| 175 | MP0005195_abnormal_posterior_eye | 0.85065724 |
| 176 | MP0002106_abnormal_muscle_physiology | 0.84920381 |
| 177 | MP0000750_abnormal_muscle_regeneration | 0.84528631 |
| 178 | MP0002752_abnormal_somatic_nervous | 0.83701679 |
| 179 | MP0009115_abnormal_fat_cell | 0.83615733 |
| 180 | MP0005423_abnormal_somatic_nervous | 0.83516638 |
| 181 | MP0003698_abnormal_male_reproductive | 0.83510926 |
| 182 | MP0000955_abnormal_spinal_cord | 0.81620386 |
| 183 | MP0001501_abnormal_sleep_pattern | 0.81445378 |
| 184 | MP0000647_abnormal_sebaceous_gland | 0.80969240 |
| 185 | MP0005389_reproductive_system_phenotype | 0.80719359 |
| 186 | MP0002928_abnormal_bile_duct | 0.80294907 |
| 187 | MP0001324_abnormal_eye_pigmentation | 0.80284250 |
| 188 | MP0004043_abnormal_pH_regulation | 0.80257265 |
| 189 | MP0005075_abnormal_melanosome_morpholog | 0.79964473 |
| 190 | MP0005391_vision/eye_phenotype | 0.78665622 |
| 191 | MP0008961_abnormal_basal_metabolism | 0.77417870 |
| 192 | MP0003633_abnormal_nervous_system | 0.77127621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 4.07401570 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.02602641 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.98821122 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 3.77688508 |
| 5 | Progressive macrocephaly (HP:0004481) | 3.70230652 |
| 6 | Medial flaring of the eyebrow (HP:0010747) | 3.62238460 |
| 7 | * Mitochondrial inheritance (HP:0001427) | 3.59325944 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.56866806 |
| 9 | Acute encephalopathy (HP:0006846) | 3.55623156 |
| 10 | Hyperammonemia (HP:0001987) | 3.44166952 |
| 11 | Rhabdomyolysis (HP:0003201) | 3.43761135 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40623003 |
| 13 | Cerebral edema (HP:0002181) | 3.30490825 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.28491721 |
| 15 | Gait imbalance (HP:0002141) | 3.21826663 |
| 16 | True hermaphroditism (HP:0010459) | 3.18050665 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.17464647 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.17464647 |
| 19 | Pancreatic cysts (HP:0001737) | 3.16663021 |
| 20 | Congenital primary aphakia (HP:0007707) | 3.16426032 |
| 21 | * Increased CSF lactate (HP:0002490) | 3.12574624 |
| 22 | Nausea (HP:0002018) | 3.05090324 |
| 23 | Exercise-induced myalgia (HP:0003738) | 3.02996804 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.02446419 |
| 25 | Hyperglycinuria (HP:0003108) | 2.99557112 |
| 26 | Nephronophthisis (HP:0000090) | 2.99282686 |
| 27 | Ketosis (HP:0001946) | 2.98810624 |
| 28 | Methylmalonic acidemia (HP:0002912) | 2.98708739 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 2.92972570 |
| 30 | Ketoacidosis (HP:0001993) | 2.90749842 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89270888 |
| 32 | Nephrogenic diabetes insipidus (HP:0009806) | 2.86759845 |
| 33 | Xanthomatosis (HP:0000991) | 2.76925906 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 2.76268943 |
| 35 | Hyperalaninemia (HP:0003348) | 2.76268943 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.76268943 |
| 37 | Dicarboxylic aciduria (HP:0003215) | 2.72201436 |
| 38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72201436 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.72174883 |
| 40 | Deep venous thrombosis (HP:0002625) | 2.71715906 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70388120 |
| 42 | Leukodystrophy (HP:0002415) | 2.68786917 |
| 43 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.66362585 |
| 44 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.66362585 |
| 45 | Abnormal ciliary motility (HP:0012262) | 2.66099040 |
| 46 | Genital tract atresia (HP:0001827) | 2.64614741 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64377071 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.64377071 |
| 49 | * Increased hepatocellular lipid droplets (HP:0006565) | 2.62456788 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.61891151 |
| 51 | Complement deficiency (HP:0004431) | 2.61081575 |
| 52 | * Lipid accumulation in hepatocytes (HP:0006561) | 2.60146296 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.60002421 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.56818931 |
| 55 | Eczematoid dermatitis (HP:0000976) | 2.55121196 |
| 56 | Vaginal atresia (HP:0000148) | 2.54708217 |
| 57 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.50489577 |
| 58 | Hypothermia (HP:0002045) | 2.47084244 |
| 59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46828344 |
| 60 | Conjunctival hamartoma (HP:0100780) | 2.45757239 |
| 61 | Absent/shortened dynein arms (HP:0200106) | 2.44548943 |
| 62 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.44548943 |
| 63 | Hypobetalipoproteinemia (HP:0003563) | 2.42835045 |
| 64 | * Lactic acidosis (HP:0003128) | 2.41193938 |
| 65 | Palpitations (HP:0001962) | 2.38496979 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.38238345 |
| 67 | Methylmalonic aciduria (HP:0012120) | 2.36285552 |
| 68 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.35718597 |
| 69 | Hyperlipoproteinemia (HP:0010980) | 2.35649790 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.35611129 |
| 71 | Polycythemia (HP:0001901) | 2.33331422 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.31905577 |
| 73 | Myocardial infarction (HP:0001658) | 2.30941661 |
| 74 | Intrahepatic cholestasis (HP:0001406) | 2.30346820 |
| 75 | Esophageal neoplasm (HP:0100751) | 2.29881229 |
| 76 | Neoplasm of head and neck (HP:0012288) | 2.29881229 |
| 77 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.28080976 |
| 78 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.28080976 |
| 79 | Ventricular tachycardia (HP:0004756) | 2.28050649 |
| 80 | Chronic otitis media (HP:0000389) | 2.27411474 |
| 81 | Optic disc pallor (HP:0000543) | 2.26028289 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.25312020 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.24954648 |
| 84 | Lipoatrophy (HP:0100578) | 2.24738741 |
| 85 | Hypoalphalipoproteinemia (HP:0003233) | 2.24729535 |
| 86 | Hypolipoproteinemia (HP:0010981) | 2.23816750 |
| 87 | Sudden death (HP:0001699) | 2.23574463 |
| 88 | Lethargy (HP:0001254) | 2.22131897 |
| 89 | * Increased serum lactate (HP:0002151) | 2.21113742 |
| 90 | Rhinitis (HP:0012384) | 2.20175937 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.19393126 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.19393126 |
| 93 | Frequent falls (HP:0002359) | 2.17843822 |
| 94 | Subaortic stenosis (HP:0001682) | 2.17808878 |
| 95 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17808878 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.16200929 |
| 97 | Respiratory failure (HP:0002878) | 2.16035429 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15608219 |
| 99 | * Renal Fanconi syndrome (HP:0001994) | 2.12453278 |
| 100 | Hepatocellular carcinoma (HP:0001402) | 2.11950287 |
| 101 | Hypertriglyceridemia (HP:0002155) | 2.10213988 |
| 102 | Hematochezia (HP:0002573) | 2.09812569 |
| 103 | Hyperglycinemia (HP:0002154) | 2.09762374 |
| 104 | Increased connective tissue (HP:0009025) | 2.09725193 |
| 105 | Tetraparesis (HP:0002273) | 2.09172964 |
| 106 | * Increased intramyocellular lipid droplets (HP:0012240) | 2.09047256 |
| 107 | Skin nodule (HP:0200036) | 2.08211578 |
| 108 | Oral leukoplakia (HP:0002745) | 2.07889432 |
| 109 | Multiple enchondromatosis (HP:0005701) | 2.03097179 |
| 110 | Epidermoid cyst (HP:0200040) | 2.02841645 |
| 111 | Recurrent viral infections (HP:0004429) | 2.01620381 |
| 112 | Focal motor seizures (HP:0011153) | 2.00907885 |
| 113 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00838943 |
| 114 | Esophageal varix (HP:0002040) | 2.00537112 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.98783827 |
| 116 | Neonatal death (HP:0003811) | 1.98716500 |
| 117 | Metabolic acidosis (HP:0001942) | 1.98478779 |
| 118 | Hypercholesterolemia (HP:0003124) | 1.97506515 |
| 119 | Increased mean platelet volume (HP:0011877) | 1.97098094 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 1.97025644 |
| 121 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96840224 |
| 122 | Polydipsia (HP:0001959) | 1.96351575 |
| 123 | Abnormal drinking behavior (HP:0030082) | 1.96351575 |
| 124 | Postaxial foot polydactyly (HP:0001830) | 1.95380002 |
| 125 | Abnormality of complement system (HP:0005339) | 1.93054650 |
| 126 | Postaxial hand polydactyly (HP:0001162) | 1.92907079 |
| 127 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92194791 |
| 128 | Gingival bleeding (HP:0000225) | 1.92005933 |
| 129 | Hyporeflexia of lower limbs (HP:0002600) | 1.91728390 |
| 130 | Calf muscle hypertrophy (HP:0008981) | 1.91306763 |
| 131 | Chronic hepatic failure (HP:0100626) | 1.91275775 |
| 132 | Neoplasm of the adrenal gland (HP:0100631) | 1.90777432 |
| 133 | * Exercise intolerance (HP:0003546) | 1.90324533 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 1.90299034 |
| 135 | Type II lissencephaly (HP:0007260) | 1.90012801 |
| 136 | Cerebellar dysplasia (HP:0007033) | 1.89528967 |
| 137 | Mucosal telangiectasiae (HP:0100579) | 1.89247092 |
| 138 | * Glycosuria (HP:0003076) | 1.88970620 |
| 139 | * Abnormality of urine glucose concentration (HP:0011016) | 1.88970620 |
| 140 | Abnormal platelet volume (HP:0011876) | 1.88707324 |
| 141 | Increased serum ferritin (HP:0003281) | 1.88639433 |
| 142 | Abnormality of purine metabolism (HP:0004352) | 1.88170514 |
| 143 | Increased serum pyruvate (HP:0003542) | 1.86174826 |
| 144 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.86014412 |
| 145 | Specific learning disability (HP:0001328) | 1.85268620 |
| 146 | Poor coordination (HP:0002370) | 1.84877843 |
| 147 | Mitral stenosis (HP:0001718) | 1.83893987 |
| 148 | Proximal tubulopathy (HP:0000114) | 1.83703514 |
| 149 | Broad foot (HP:0001769) | 1.83421315 |
| 150 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82352311 |
| 151 | Cholelithiasis (HP:0001081) | 1.82143233 |
| 152 | Mucopolysacchariduria (HP:0008155) | 1.82136966 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82136966 |
| 154 | Polyphagia (HP:0002591) | 1.81626708 |
| 155 | Lymphangioma (HP:0100764) | 1.81297960 |
| 156 | Drooling (HP:0002307) | 1.81230474 |
| 157 | Anencephaly (HP:0002323) | 1.80803158 |
| 158 | Bile duct proliferation (HP:0001408) | 1.80771526 |
| 159 | Abnormal biliary tract physiology (HP:0012439) | 1.80771526 |
| 160 | Renal cortical cysts (HP:0000803) | 1.80707369 |
| 161 | Tubulointerstitial nephritis (HP:0001970) | 1.80339866 |
| 162 | Hypoglycemic seizures (HP:0002173) | 1.80263809 |
| 163 | Urticaria (HP:0001025) | 1.80079999 |
| 164 | Short tibia (HP:0005736) | 1.78543702 |
| 165 | Sclerocornea (HP:0000647) | 1.78176515 |
| 166 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.77943953 |
| 167 | Attenuation of retinal blood vessels (HP:0007843) | 1.77929882 |
| 168 | Hyperventilation (HP:0002883) | 1.77878666 |
| 169 | Abnormality of iron homeostasis (HP:0011031) | 1.77812049 |
| 170 | * Increased muscle lipid content (HP:0009058) | 1.76439619 |
| 171 | Abnormality of vitamin B metabolism (HP:0004340) | 1.76242920 |
| 172 | Abnormality of serum amino acid levels (HP:0003112) | 1.76106128 |
| 173 | CNS hypomyelination (HP:0003429) | 1.75424162 |
| 174 | Hyperbilirubinemia (HP:0002904) | 1.75252646 |
| 175 | Abnormality of macrophages (HP:0004311) | 1.74788672 |
| 176 | Decreased testicular size (HP:0008734) | 1.74782079 |
| 177 | Abnormal number of erythroid precursors (HP:0012131) | 1.73378078 |
| 178 | Abnormal cartilage morphology (HP:0002763) | 1.72881442 |
| 179 | Spastic diplegia (HP:0001264) | 1.72826812 |
| 180 | Hepatic necrosis (HP:0002605) | 1.72217776 |
| 181 | Hypomagnesemia (HP:0002917) | 1.71929133 |
| 182 | Bone cyst (HP:0012062) | 1.71284873 |
| 183 | Cystic liver disease (HP:0006706) | 1.71070019 |
| 184 | Reticulocytosis (HP:0001923) | 1.70797919 |
| 185 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.70111523 |
| 186 | Occipital encephalocele (HP:0002085) | 1.69550914 |
| 187 | CNS demyelination (HP:0007305) | 1.69332256 |
| 188 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.68424573 |
| 189 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.68285572 |
| 190 | Poor suck (HP:0002033) | 1.67466593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.31126907 |
| 2 | PKN2 | 4.08964152 |
| 3 | MAP3K4 | 3.39107674 |
| 4 | MAP4K2 | 3.25450816 |
| 5 | BCKDK | 3.01102172 |
| 6 | ERN1 | 3.00935185 |
| 7 | ZAK | 2.96607488 |
| 8 | TTN | 2.63791066 |
| 9 | NEK1 | 2.58075655 |
| 10 | BRSK2 | 2.47440637 |
| 11 | TLK1 | 2.46468157 |
| 12 | TYK2 | 2.38190026 |
| 13 | MAP2K7 | 2.32726673 |
| 14 | FLT3 | 2.30081860 |
| 15 | NEK9 | 2.24700658 |
| 16 | EIF2AK3 | 2.10529314 |
| 17 | MAP4K1 | 2.06607657 |
| 18 | SIK1 | 2.06434036 |
| 19 | CASK | 2.04063364 |
| 20 | VRK1 | 2.02178122 |
| 21 | WNK3 | 2.01643948 |
| 22 | JAK3 | 1.97760852 |
| 23 | WEE1 | 1.96846664 |
| 24 | BMPR1B | 1.89659785 |
| 25 | MAP2K3 | 1.85352273 |
| 26 | TBK1 | 1.84778668 |
| 27 | TRIM28 | 1.83632773 |
| 28 | OBSCN | 1.79916761 |
| 29 | PBK | 1.74414640 |
| 30 | FGFR4 | 1.68646109 |
| 31 | PDK4 | 1.65912591 |
| 32 | PDK3 | 1.65912591 |
| 33 | VRK2 | 1.62480585 |
| 34 | TGFBR2 | 1.60679706 |
| 35 | ERBB3 | 1.59369647 |
| 36 | TNIK | 1.58235478 |
| 37 | MAPK13 | 1.57077996 |
| 38 | SRPK1 | 1.53849050 |
| 39 | MAP2K4 | 1.49615352 |
| 40 | JAK1 | 1.45601244 |
| 41 | TGFBR1 | 1.45575280 |
| 42 | MKNK1 | 1.41291203 |
| 43 | MAP3K10 | 1.41045851 |
| 44 | ZAP70 | 1.38677568 |
| 45 | LRRK2 | 1.37394461 |
| 46 | KIT | 1.33724399 |
| 47 | STK16 | 1.32697792 |
| 48 | RPS6KA4 | 1.29244073 |
| 49 | RIPK1 | 1.26576491 |
| 50 | BCR | 1.25498340 |
| 51 | NUAK1 | 1.25359589 |
| 52 | MST4 | 1.24823240 |
| 53 | TAF1 | 1.24284726 |
| 54 | MAP3K14 | 1.22203680 |
| 55 | NME2 | 1.21203303 |
| 56 | MARK1 | 1.16743238 |
| 57 | MKNK2 | 1.15817110 |
| 58 | GRK1 | 1.15346093 |
| 59 | FGFR3 | 1.14086838 |
| 60 | PTK6 | 1.13500629 |
| 61 | CSNK1G2 | 1.12497643 |
| 62 | ADRBK2 | 1.12429419 |
| 63 | CSNK1G3 | 1.12093343 |
| 64 | BUB1 | 1.11257295 |
| 65 | EEF2K | 1.09421207 |
| 66 | PLK2 | 1.07858368 |
| 67 | CSNK1G1 | 1.07162462 |
| 68 | JAK2 | 1.06626699 |
| 69 | MAP3K5 | 1.05555509 |
| 70 | DYRK2 | 1.04231026 |
| 71 | IKBKE | 1.01045462 |
| 72 | CAMKK2 | 1.01005840 |
| 73 | CAMK1D | 1.00633778 |
| 74 | PLK4 | 1.00258433 |
| 75 | CSNK1A1L | 0.96790767 |
| 76 | MYLK | 0.96556490 |
| 77 | MAPK11 | 0.96551205 |
| 78 | IRAK4 | 0.94232432 |
| 79 | BTK | 0.92899572 |
| 80 | KDR | 0.91649564 |
| 81 | STK10 | 0.90977006 |
| 82 | PIK3CG | 0.90312583 |
| 83 | STK24 | 0.89390202 |
| 84 | EIF2AK1 | 0.88978325 |
| 85 | EPHA4 | 0.88816299 |
| 86 | PLK3 | 0.87408400 |
| 87 | CDK4 | 0.87342331 |
| 88 | CDK19 | 0.87284761 |
| 89 | WNK4 | 0.86688477 |
| 90 | FGFR2 | 0.86380685 |
| 91 | STK4 | 0.85995593 |
| 92 | STK38L | 0.85834984 |
| 93 | PNCK | 0.85434638 |
| 94 | PIM2 | 0.84701200 |
| 95 | CSF1R | 0.84341565 |
| 96 | MAP3K3 | 0.83909460 |
| 97 | NME1 | 0.82210040 |
| 98 | BRSK1 | 0.81894842 |
| 99 | SCYL2 | 0.81812003 |
| 100 | TXK | 0.81758954 |
| 101 | PRKCE | 0.80707533 |
| 102 | PASK | 0.80610604 |
| 103 | EIF2AK2 | 0.80030486 |
| 104 | LMTK2 | 0.79766485 |
| 105 | DMPK | 0.79272156 |
| 106 | TEC | 0.78167042 |
| 107 | PKN1 | 0.78140155 |
| 108 | PDGFRA | 0.77310330 |
| 109 | CDK6 | 0.77163813 |
| 110 | TAOK3 | 0.76346896 |
| 111 | OXSR1 | 0.75410944 |
| 112 | MAP3K13 | 0.75237764 |
| 113 | STK39 | 0.75029335 |
| 114 | PAK3 | 0.74937481 |
| 115 | SIK3 | 0.74731800 |
| 116 | PRKCG | 0.74511791 |
| 117 | EPHA3 | 0.74250815 |
| 118 | STK3 | 0.72978724 |
| 119 | ILK | 0.72734373 |
| 120 | SYK | 0.72233935 |
| 121 | NTRK2 | 0.71265046 |
| 122 | RPS6KA5 | 0.70318878 |
| 123 | MARK3 | 0.68845394 |
| 124 | BMPR2 | 0.68802400 |
| 125 | MAP3K11 | 0.67486746 |
| 126 | IKBKB | 0.66836540 |
| 127 | FRK | 0.66659975 |
| 128 | MST1R | 0.66286269 |
| 129 | CDK3 | 0.66252021 |
| 130 | MAPK15 | 0.65132951 |
| 131 | BMX | 0.63189101 |
| 132 | PAK4 | 0.62500630 |
| 133 | UHMK1 | 0.62284425 |
| 134 | BLK | 0.60740540 |
| 135 | DYRK1A | 0.60121530 |
| 136 | PIM1 | 0.59861367 |
| 137 | TNK2 | 0.58501119 |
| 138 | PDK2 | 0.57500433 |
| 139 | DYRK3 | 0.57099340 |
| 140 | MAP3K7 | 0.56041800 |
| 141 | ITK | 0.55913294 |
| 142 | PHKG2 | 0.54624700 |
| 143 | PHKG1 | 0.54624700 |
| 144 | CHUK | 0.54414136 |
| 145 | LATS1 | 0.53873311 |
| 146 | PDK1 | 0.53761471 |
| 147 | ABL2 | 0.53493067 |
| 148 | PRKAA2 | 0.52829888 |
| 149 | CCNB1 | 0.52461034 |
| 150 | MAP3K8 | 0.51648823 |
| 151 | MINK1 | 0.51213664 |
| 152 | PRKCQ | 0.51073779 |
| 153 | NTRK3 | 0.50458749 |
| 154 | CSK | 0.50361458 |
| 155 | CDK8 | 0.50064515 |
| 156 | DAPK2 | 0.48090168 |
| 157 | TAOK2 | 0.47305357 |
| 158 | RPS6KA6 | 0.47230388 |
| 159 | SGK3 | 0.46209682 |
| 160 | PRKAA1 | 0.45318761 |
| 161 | PIK3CA | 0.45259800 |
| 162 | HCK | 0.43363600 |
| 163 | MAPKAPK5 | 0.43054360 |
| 164 | RPS6KC1 | 0.42801704 |
| 165 | RPS6KL1 | 0.42801704 |
| 166 | PINK1 | 0.42300903 |
| 167 | PRKD3 | 0.42038739 |
| 168 | RET | 0.41770715 |
| 169 | INSRR | 0.41484956 |
| 170 | CAMK2A | 0.40890142 |
| 171 | ACVR1B | 0.40624365 |
| 172 | CDC7 | 0.39823729 |
| 173 | LYN | 0.39614270 |
| 174 | EGFR | 0.38023384 |
| 175 | PLK1 | 0.37857106 |
| 176 | ALK | 0.37109426 |
| 177 | MAP2K6 | 0.36283302 |
| 178 | CSNK2A1 | 0.35894460 |
| 179 | CSNK1A1 | 0.34815535 |
| 180 | LCK | 0.34522794 |
| 181 | PRKACA | 0.32829128 |
| 182 | ATR | 0.31234671 |
| 183 | STK11 | 0.29063920 |
| 184 | PRKG1 | 0.28042678 |
| 185 | GRK7 | 0.27800459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.90304315 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.80625354 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.46913165 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45219076 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.29967249 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.22993383 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.95831158 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.89764129 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75103749 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.59468967 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57674650 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.56736931 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40648709 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.36585352 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32929039 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.26458004 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.26323872 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 2.23657530 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 2.16722813 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.14728273 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.14305708 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 2.08487820 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 2.08159564 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91602699 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84038536 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81688693 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75791234 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74188482 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.69907613 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67215932 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.60125794 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.56982864 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.56171718 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.55632201 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.50643750 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48751724 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.48590607 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46095608 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45574625 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43533205 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42556391 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.40172747 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.40041792 |
| 44 | Nicotine addiction_Homo sapiens_hsa05033 | 1.38980533 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34870908 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31697598 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30765372 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 1.30361746 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 1.30116475 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30023173 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.29553566 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24673232 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.23127865 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.20303966 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19838754 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 1.17858062 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15959403 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13604472 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11342136 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05798943 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 1.02575725 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02373280 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 1.01891441 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00641985 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00564921 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99456863 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.97383988 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96612538 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96412422 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96363910 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94730794 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94568763 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93866828 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93453050 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93353481 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91470949 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90476515 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89476549 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88321070 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86550921 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86371246 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86164920 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84915563 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.84446017 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81619130 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.80446092 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.80223584 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79940970 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79793560 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.78257766 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76507491 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76463057 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75813213 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75456083 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73913185 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72726745 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72163022 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71683608 |
| 99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71524390 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70192115 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.68966629 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67627554 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.67480803 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67215373 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66695901 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66637880 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65784681 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.65705423 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.65472118 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.64783721 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64508957 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.62804078 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62564915 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62393766 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61667575 |
| 116 | DNA replication_Homo sapiens_hsa03030 | 0.60039050 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59547386 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58948498 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.58945143 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56868490 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56215370 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55883739 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54929883 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54843280 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53328797 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52299443 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.51531769 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51068371 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50789563 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.49061433 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48033805 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47942622 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47170116 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46961969 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46466650 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45975218 |
| 137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45938238 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45652704 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45487093 |
| 140 | RNA transport_Homo sapiens_hsa03013 | 0.43766819 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43473513 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43015967 |
| 143 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42225352 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41924820 |
| 145 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41692244 |
| 146 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41506408 |
| 147 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40908451 |
| 148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40099674 |
| 149 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39910096 |
| 150 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39630907 |
| 151 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39261867 |
| 152 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39143704 |
| 153 | Hepatitis B_Homo sapiens_hsa05161 | 0.38331817 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37554369 |
| 155 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37483303 |
| 156 | Malaria_Homo sapiens_hsa05144 | 0.37261293 |
| 157 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36803478 |
| 158 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34673061 |
| 159 | Salivary secretion_Homo sapiens_hsa04970 | 0.34253453 |
| 160 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33900958 |
| 161 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33849122 |
| 162 | Platelet activation_Homo sapiens_hsa04611 | 0.32132697 |
| 163 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31389848 |
| 164 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.30501883 |
| 165 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30447094 |
| 166 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.30030332 |
| 167 | Amoebiasis_Homo sapiens_hsa05146 | 0.28413381 |

